Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate/albuterol sulfate combination trial in adolescents and adults with asthma
PACTR202605851902406Phase 3Not yet recruiting
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate and salbutamol in asthma (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
fluticasone propionatesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on PACTR202605851902406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605851902406.